90,956
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Management of hypertensive emergencies: a practical approach

, , , , , , , & show all
Pages 208-219 | Received 03 Feb 2021, Accepted 26 Mar 2021, Published online: 08 May 2021

References

  • van den Born B-JH, Lip GYH, Brguljan-Hitij J, et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Hear J – Cardiovasc Pharmacother. 2019;5(1):37–46.
  • Shorr AF, Zilberberg MD, Sun X, et al. Severe acute hypertension among inpatients admitted from the emergency department. J Hosp Med. 2012;7(3):203–210.
  • Zampaglione B, Pascale C, Marchisio M, et al. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension. 1996;27(1):144–147.
  • Hannemann A, Friedrich N, Lüdemann J, et al. Reference intervals for aldosterone, renin, and the aldosterone-to-renin ratio in the population-based study of health in pomerania (SHIP-1). Horm Metab Res. 2010;42(06):392–399.
  • Janke A, McNaughton C, Brody A, et al. Trends in the incidence of hypertensive emergencies in US Emergency Departments From 2006 to 2013. J Am Heart Assoc. 2016;5(12):e004511.
  • Martin J, Higashiama E, Garcia E, et al. Hypertensive crisis profile. Prevalence and clinical presentation. Arq Bras Cardiol. 2004;83(2):131–136.
  • Polgreen LA, Suneja M, Tang F, et al. Increasing trend in admissions for malignant hypertension and hypertensive encephalopathy in the United States. Hypertension. 2015;65(5):1002–1007.
  • Salvetti M, Paini A, Colonetti E, et al. Hypertensive emergencies and urgencies: a single-centre experience in Northern Italy 2008–2015. J Hypertens. 2020;38(1):52–58.
  • Armitage LC, Whelan ME, Watkinson PJ, et al. Screening for hypertension using emergency department blood pressure measurements can identify patients with undiagnosed hypertension: a systematic review with meta-analysis. J Clin Hypertens. 2019;21(9):1415–1425.
  • Kotruchin P, Mitsungnern T, Ruangsaisong R, et al. Hypertensive urgency treatment and outcomes in a Northeast Thai population: the results from the hypertension registry program. High Blood Press Cardiovasc Prev. 2018;25(3):309–315.
  • Shao P, Sawe H, Murray B, et al. Profile of patients with hypertensive urgency and emergency presenting to an urban emergency department of a tertiary referral hospital in Tanzania. BMC Cardiovasc Disord. 2018;18(1):158.
  • Kumar N, Simek S, Garg N, et al. Thirty-day readmissions after hospitalization for hypertensive emergency. Hypertension. 2019;73(1):60–67.
  • Rossi GP, Seccia TM, Pessina AC. Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension. Crit Rev Clin Lab Sci. 2007;44(1):1–85.
  • Rossitto G, Cesari M, Ceolotto G, et al. Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone-renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design. J Hum Hypertens. 2019;33(2):167–171.
  • Azizi M, Sapoval M, Gosse P, et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet. 2015;385(9981):1957–1965.
  • Lip GY, Beevers M, Beevers G. The failure of malignant hypertension to decline: a survey of 24 years’ experience in a multiracial population in England. J Hypertens. 1994;12(11):1297–1305.
  • Van den Born B-JH, Koopmans RP, Groeneveld JO, et al. Ethnic disparities in the incidence, presentation and complications of malignant hypertension. J Hypertens. 2006;24(11):2299–2304.
  • Rossi GP, Seccia TM, Barton M, et al. Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: general mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society. J Hypertens. 2018;36 (3):451–461.
  • Rossi G, Seccia Y, Barton M, et al. Endothelial factors in the pathogenesis and treatment of chronic kidney disease part II: role in disease conditions: a joint consensus statement from the european society of hypertension working group on endothelin and endothelial factors and the Japanese. J Hypertens. 2018;36(3):426–471.
  • Blumenfeld JD, Laragh JH. Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens. 2001;14(11 Pt 1):1154–1167.
  • Palatini P. ECG changes during minoxidil therapy. Arch Intern Med. 1981;141(6):817.
  • Ahmed N, NäSman P, Wahlgren NG. Outcome after acute stroke. Stroke. 2000;31(6):1250–1255.
  • Sandset EC, Bath PMW, Boysen G, et al . The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet. 2011;377(9767):741–750.
  • Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041.
  • ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925–1938.
  • Gierthmühlen J, Allardt A, Sawade M, et al. Role of sympathetic nervous system in activity-induced cerebral perfusion. J Neurol. 2010;257(11):1798–1805.
  • Bartynski WS. Posterior reversible encephalopathy syndrome, Part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29(6):1036–1042.
  • Mishima E, Funayama Y, Suzuki T, et al. Concurrent analogous organ damage in the brain, eyes, and kidneys in malignant hypertension: reversible encephalopathy, serous retinal detachment, and proteinuria. Hypertens Res. 2021;44(1):88–97.
  • Miller J, Suchdev K, Jayaprakash N, et al. New developments in hypertensive encephalopathy. Curr Hypertens Rep. 2018;20(2):13.
  • Narbone MC, Musolino R, Granata F, et al. PRES: posterior or potentially reversible encephalopathy syndrome? Neurol Sci. 2006;27(3):187–189.
  • Legriel S, Schraub O, Azoulay E, et al. Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS One. 2012;7(9):e44534.
  • Rossi GP, Ceolotto G, Rossitto G, et al. Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension. Clin Chem Lab Med. 2016:54(9):1441–1450.
  • Bruce BB. Nonmydriatic ocular fundus photography in the emergency department: how it can benefit neurologists. Semin Neurol. 2015;35(5):491–495.
  • Fox L, Cohney S, Kausman J, et al. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand. Intern Med J. 2018;48(6):624–636.
  • Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2011;32(24):3147–3197.
  • Webster K, Fishburn S, Maresh M, et al. Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance. BMJ. 2019;366(September):1–8.
  • Steegers EA, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet. 2010;376(9741):631–644.
  • Acog Committee On Obstetric Practice. ACOG Practice bulletin: diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002;77(1):67–75.
  • Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018;39(33):3021–3104.
  • Olsson C, Thelin S, Ståhle E, et al. Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002. Circulation. 2006;114(24):2611–2618.
  • Howard DPJ, Banerjee A, Fairhead JF, et al. Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study. Circulation. 2013;127(20):2031–2037.
  • Clouse WD, Hallett JW, Schaff H V, et al. Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc. 2004;79(2):176–180.
  • Collet J-P, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2020;42(14):1289–1367.
  • Dal Palu C, Pessina AC, Semplicini A, et al. Intravenous labetalol in severe hypertension. Br J Clin Pharmacol. 1982;13(1 Suppl):97S–99S.
  • Bravo EL, Fouad-Tarazi F, Rossi G, et al. A reevaluation of the hemodynamics of pheochromocytoma. Hypertension. 1990;15(2 Suppl):I128–I131.
  • Grossman E, Nadler M, Sharabi Y, et al. Antianxiety treatment in patients with excessive hypertension. Am J Hypertens. 2005;18(9 Pt):1174–1177.
  • Wilson DJ, Wallin JD, Vlachakis ND, et al. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies. Am J Med. 1983;75(4A):95–102.
  • Fischberg GM, Lozano E, Rajamani K, et al. Stroke precipitated by moderate blood pressure reduction. J Emerg Med. 2000;19(4):339–346.
  • Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 Update to the 2018 Guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association/American Stroke. Stroke. 2019;50(12):e344–e418.
  • Hemphill JC, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke. 2015;46(7):2032–2060.
  • Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Socie. Eur Heart J. 2018;39(2):119–177.
  • Singh A, Khaja A, Alpert MA. Cocaine and aortic dissection. Vasc Med. 2010;15(2):127–133.
  • Papadopoulos DP, Sanidas EA, Viniou NA, et al. Cardiovascular hypertensive emergencies. Curr Hypertens Rep. 2015;17(2):5.
  • Padilha WSC, Annes M, Massant CG, et al. Cocaine-induced renal artery dissection as a cause of secondary hypertension: a rare presentation. Am J Case Rep. 2020;21:e921565.
  • Torresan F, Rossitto G, Bisogni V, et al. Resolution of drug-resistant hypertension by adrenal vein sampling-guided adrenalectomy: a proof-of-concept study. Clin Sci. 2020;134(11):1265–1278.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.